Selecta Biosciences (SELB) Peer Comparison

$0.75

$0.03 (4.51%)

As on 26-Dec-2023 09:30EDT

Market cap

$-- Mln

Revenue (TTM)

$35 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Market cap ($ Mln)	--	9,554	3
Revenue ($ Mln)	35	771	1
Net Profit ($ Mln)	-40.25	-61.10	-88.35
Net Margin (%)	-85.70	--	-10,394.00
RoE (%)	-59.67	-3.97	-646.46
Price to Earnings	--	--	--
Price-To-Book	--	2.64	0.65

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Operating Revenue	110.78	39.61	0.00
Cost of Revenue	--	31.99	0.54
Gross Profit	110.78	7.62	-0.54
Operating Expenses	96.24	11.79	70.88
Operating Profit (EBIT)	14.54	-4.17	-71.42
Other Income	23.26	--	1.54
Profit before Tax	34.77	-3.08	-70.19
Provision for Tax	-0.61	-6.67	1.27
Profit after Tax (Net Income)	35.38	3.59	-71.46
Minority Interest	--	--	--
Consolidated Profit	35.38	10.99	-71.46

Liabilities ($ Mln)

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Shareholder's Funds	93.83	16.82	138.85
Minority Interest	--	--	--
Non-Current Liabilities	46.98	6.00	2.28
Current Liabilities	25.08	23.94	10.68
Total Liabilities	165.89	46.76	151.81

Assets ($ Mln)

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Non-Current Assets	17.75	37.58	3.59
Current Assets	148.14	9.17	148.22
Total Assets	165.89	46.76	151.81
Total Debt*	37.93	12.45	2.79
Net Current Assets	123.06	-14.77	137.54

Cashflow ($ Mln)

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Cash From Operating Activities	-31.63	-3.06	-59.73
Cash Flow from Investing Activities	-15.00	-1.51	-0.69
Cash from Financing Activities	39.22	3.98	187.54
Net Cash Inflow / Outflow	-7.42	--	-60.42

Ratios

Profitability Ratios

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
ROCE (%)	37.33	26.36	-40.42
ROE (%)	60.82	88.17	-40.74
ROA (%)	21.72	11.59	-38.20
EBIT Margin (%)	--	--	--
Net Margin (%)	26.39	9.06	-4,637.12
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Revenue Growth (%)	0.30	-0.01	--
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	237.73	121.25	-5.27
EPS Growth (%)	--	--	0.06
Book Value Growth (%)	--	--	--

Valuation Ratios

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Price / Earnings	--	--	-0.93
Price / Book Value	--	--	0.48
Dividend Yield (%)	--	--	--
EV/EBITDA	-5.98	-5.38	1.06
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Debt to Equity	0.40	0.74	0.02
Short term debt to equity ratio	0.11	0.40	0.00
Current Ratio	5.91	0.38	13.88
Quick Ratio	--	0.37	14.03
Interest Coverage	4.80	-5.15	-231.40

Operating Efficiency Ratios

	Selecta Biosciences (SELB)	Janone Inc (JAN)	IO Biotech Inc (IOBT)
Debtors to sales (%)	8.81	20.00	--
Asset Turnover	0.68	1.28	0.00
Receivable days	32.43	55.98	--
Inventory Days	--	8.99	-1,225.62
Payable days	--	68.30	2,682.56
Cash Conversion Cycle	--	-3.33	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly